IP Library Granted Patent US 7,879,614
Granted Patent B2
US 7,879,614 · App. 11/958,597 · Granted Feb 1, 2011

Methods for detection of breast cancer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,614
App. No.
11/958,597
Granted
Feb 1, 2011
Kind
B2
Abstract

The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of breast fluids with an aldehyde detecting reagent without any prewashing. The appearance in breast fluids of a marker that is detected by an aldehyde detecting reagent, such as a Schiff's reagent, correlates very well with the disease status of the breast cancer subjects from which the fluids were obtained. Screening test kits are also provided.

Claims (36)

1. A method for detecting neoplasia, a precancerous condition, or cancer of the breast in a subject comprising:

treating a sample of breast fluid from the subject with an aldehyde detecting reagent, wherein the sample of breast fluid comprises duct secretion obtained from a nipple;

wherein the breast fluid is treated directly, such that the breast fluid does not undergo pretreatment or modification prior to contacting the aldehyde detecting reagent,

where the detection of a change in a detectable property produced by treating the breast fluid with the aldehyde detecting reagent compared to a control is indicative of neoplasia, a precancerous condition, or cancer;

wherein the detectable property comprises one or more of: color, spectral properties, spectral absorption, fluorescence, chemi-luminescence, mass spectral properties or chromatographic properties.

2. A method of claim 1 comprising the following steps:

a) obtaining a sample of breast fluid from a subject;

b) depositing the sample on a solid support;

c) treating the sample with an aldehyde detecting reagent without any prewashing;

d) detecting a colorimetric change produced in the sample, where detection of a colorimetric change compared to a control is indicative of neoplasia, a precancerous condition, or cancer of the breast.

3. A method of claim 2 wherein the sample contains an aldehyde marker associated with breast cancer, and comprising in step d) detecting the presence of the aldehyde marker in the sample.

4. A method of claim 3 wherein the aldehyde marker is capable of reacting with a Schiff's reagent to produce a colorimetric change.

5. A method as claimed in claim 4 wherein the aldehyde marker comprises low molecular weight aldehydes that are soluble in water.

6. A method of claim 4 wherein the aldehyde marker comprises aldehydes derived from plasmalogens.

7. A method as claimed in claim 2 wherein the sample is additionally screened for the presence of other markers that are indicators of breast cancer.

8. A method of claim 1 for detecting a neoplasia, a precancerous condition, or cancer of the breast in a subject, which method comprises:

a) obtaining a sample of breast fluid from a subject;

b) depositing the sample on a solid support;

c) treating the sample on the support with a Schiff's reagent without any prewashing; and

d) detecting a colorimetric change resulting from the reaction of the sample and Schiff's reagent wherein a colorimetric change is indicative of neoplasia, a precancerous condition, or cancer of the breast.

9. A method of claim 1 for detecting the presence of neoplasia, a precancerous condition, or cancer of the breast, which method comprises:

(a) obtaining a sample of breast fluid from the nipple of one or both non-lactating breasts of a subject;

(b) depositing the collected sample on a solid water-insoluble support;

(c) treating the sample on the support with a Schiff's reagent without any prewashing;

(d) washing the sample; and

(e) screening for neoplasia, a precancerous condition, or cancer of the breast by persistent purple coloration produced in the sample.

10. A method as claimed in claim 1 wherein the sample is adsorbed on a water-insoluble substrate.

11. A method as claimed in claim 10 wherein the coloration is distinguished from other colorations.

12. A method as claimed in claim 10 wherein the water-insoluble substrate is made from polyester fibre or glass fibre fabrics.

13. A method of claim 1 for detecting the presence of neoplasia, a precancerous condition, or cancer of the breast, which method consists essentially of obtaining a sample of breast fluid from a subject; directly treating the sample with a Schiff's reagent and, detecting neoplasia, a precancerous condition, or cancer of the breast based upon the coloration produced in the sample by the treatment.

14. A method of claim 1 for detecting the presence of neoplasia, a precancerous condition, or cancer of the breast, which method consists essentially of obtaining a sample of breast fluid from a subject; treating the sample with a Schiff's reagent without a step of adding an enzyme and, detecting neoplasia, a precancerous condition, or cancer of the breast.

15. A method as claimed in claim 1 comprising:

a) obtaining a sample of breast fluid from a subject;

b) depositing the sample on a solid support;

c) treating the sample with a step consisting essentially of adding a Schiff's reagent; and

e) detecting a colorimetric change resulting from the reaction of aldehyde markers on the sample and Schiff's reagent wherein a colorimetric change is indicative of neoplasia, precancer or cancer of the breast.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE CHANGE OF NAME PREVIOUSLY RECORDED AT REEL: 051783 FRAME: 0477. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 10, 2020
From: ATOSSA GENETICS INC.
To: ATOSSA THERAPEUTICS, INC.
Reel/Frame 054372/0976 →
CHANGE OF NAME Recorded Feb 3, 2020
From: ATOSSA GENETICS INC.
To: ATOSSA THERAPEUTICS, INC.
Reel/Frame 051783/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2011
From: DR. SUSAN LOVE RESEARCH FOUNDATION
To: ATOSSA GENETICS, INC.
Reel/Frame 027013/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2011
From: KREPINSKY, JIRI J; YEUNG, KA SING; FURRER, RUDOLF
To: DR. SUSAN LOVE RESEARCH FOUNDATION
Reel/Frame 026996/0748 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2010
From: KREPINSKY, JIRI JAN; FURRER, RUDOLF; YEUNG, KA SING
To: DR. SUSAN LOVE RESEARCH FOUNDATION
Reel/Frame 024164/0272 →